DLH Announces Appointment to its Board of Directors
August 05 2020 - 8:00AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”) today announced the appointment of Stephen J.
Zelkowicz to its board of directors, effective immediately, with an
initial term expiring with the 2021 Annual Shareholder’s Meeting.
With this addition, there will be eight members on the Company’s
Board.
"I am pleased to welcome Steve to our Board of
Directors at this exciting time in our history,” said DLH President
and Chief Executive Officer Zach Parker. “He brings strong
analytical skills and a depth of knowledge honed within the capital
markets industry, including 20 years’ experience with Wynnefield
Capital, our largest shareholder and his current firm. He has
served on the boards of companies, both public and private, and we
are confident his expertise and business acumen will add important
perspective to our Board. His counsel will be invaluable as we
continue to grow the business and work to generate shareholder
value."
Mr. Zelkowicz currently serves on the board of
Summer Infant, Inc. (NASDAQ:SUMR), where he is chair of the
Governance and Nominating Committee and a member of the
Compensation Committee. Mr. Zelkowicz holds a B.A. from the
University of Pennsylvania and a M.B.A. from Columbia
University.
About DLHDLH (NASDAQ:DLHC)
serves federal government clients throughout the United States and
abroad delivering technology enabled solutions in key health and
human services programs. The Company's seven core competencies
include secure data analytics, clinical trials and laboratory
services, case management, performance evaluation, system
modernization, operational logistics and readiness, and strategic
digital communications. DLH has over 2,000 employees serving
numerous government agencies. For more information, visit the
corporate website at www.dlhcorp.com.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:This press
release may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These
statements relate to future events or DLH’s future financial
performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that the
Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
These statements reflect our belief and assumptions as to future
events that may not prove to be accurate. Our actual results may
differ materially from such forward-looking statements made in this
release due to a variety of factors, including: the outbreak of the
novel coronavirus (“COVID-19”), including the measures to reduce
its spread, and its impact on the economy and demand for our
services, are uncertain, cannot be predicted, and may precipitate
or exacerbate other risks and uncertainties; the risk that we will
not realize the anticipated benefits of an acquisition; contract
awards in connection with re-competes for present business and/or
competition for new business; compliance with bank financial and
other covenants; changes in client budgetary priorities; government
contract procurement (such as bid protest, small business set
asides, loss of work due to organizational conflicts of interest,
etc.) and termination risks; the ability to successfully integrate
the operations of future acquisitions; and other risks described in
our SEC filings. For a discussion of such risks and uncertainties
which could cause actual results to differ from those contained in
the forward-looking statements, see “Risk Factors” in the Company’s
periodic reports filed with the SEC, including our Annual Report on
Form 10-K for the fiscal year ended September 30, 2019, as well as
subsequent reports filed thereafter. The forward-looking statements
contained herein are not historical facts, but rather are based on
current expectations, estimates, assumptions and projections about
our industry and business. Such forward-looking statements
are made as of the date hereof and may become outdated over time.
The Company does not assume any responsibility for updating
forward-looking statements, except as may be required by law.
CONTACTS:
INVESTOR RELATIONS |
Chris Witty |
Phone: 646-438-9385 cwitty@darrowir.com |
Summer Infant (NASDAQ:SUMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Summer Infant (NASDAQ:SUMR)
Historical Stock Chart
From Apr 2023 to Apr 2024